Endogenous cannabinoids revisited: A biochemistry perspective

Prostaglandins and Other Lipid Mediators

Volumn 102-103, Issue , 2013, Pages 13-30

  Fonseca, B M ^a   Costa, M A ^a   Almada, M ^a   Correia Da Silva, G ^a   Teixeira, N A ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

2 Arachidonylglycerol; Anandamide; Endocannabinoids

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2 ARACHIDONOYLGLYCERYL ETHER; AMINE; ANANDAMIDE; CANNABINOID RECEPTOR; ENDOCANNABINOID; ETHER; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; GLYCINE; N ACYLETHANOLAMINE; N ARACHIDONOYL GLYCINE; OLEAMIDE; PALMIDROL; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

BIOCHEMISTRY; BIOSYNTHESIS; CHEMICAL STRUCTURE; HUMAN; METABOLITE; NONHUMAN; REVIEW; SYNTHESIS;

ARACHIDONIC ACIDS; BRAIN; CANNABINOID RECEPTOR AGONISTS; CANNABIS; ENDOCANNABINOIDS; GLYCERIDES; HUMANS; POLYUNSATURATED ALKAMIDES;

EID: 84877081113     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2013.02.002     Document Type: Review

References (252)

1. I.B. Adams, and B.R. Martin Cannabis: pharmacology and toxicology in animals and humans Addiction 91 1996 1585 1614
2. R. Mechoulam, and Y. Gaoni Hashish. IV The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids Tetrahedron 21 1965 1223 1229
3. R.K. Razdan Structure-activity relationships in cannabinoids Pharmacol Rev 38 1986 75 149
4. D.R. Compton, L.H. Gold, S.J. Ward, R.L. Balster, and B.R. Martin Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol J Pharmacol Exp Ther 263 1992 1118 1126
5. A.C. Howlett, and R.M. Fleming Cannabinoid Inhibition of Adenylate-Cyclase - Pharmacology of the Response in Neuro-Blastoma Cell-Membranes Mol Pharmacol 26 1984 532 538
6. A.C. Howlett Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes Mol Pharmacol 27 1985 429 436
7. W.A. Devane, F.A. Dysarz, M.R. 3rd Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613
8. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
9. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
10. E. Fride Endocannabinoids in the central nervous system - an overview Prostaglandins Leukot Essent Fatty Acids 66 2002 221 233
11. B.M. Fonseca, G. Correia-da-Silva, A.H. Taylor, J.C. Konje, S.C. Bell, and N.A. Teixeira Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development Reprod Biol Endocrinol 7 2009 121
12. M.R. El-Talatini, A.H. Taylor, J.C. Elson, L. Brown, A.C. Davidson, and J.C. Konje Localisation and function of the endocannabinoid system in the human ovary PLoS One 4 2009 e4579
13. B.M. Fonseca, G. Correia-da-Silva, and A.H. Taylor Characterisation of the endocannabinoid system in rat haemochorial placenta Reprod Toxicol 34 2012 347 356
14. S.D. Skaper, A. Buriani, and R. Dal Toso The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons Proc Natl Acad Sci USA 93 1996 3984 3989
15. M.D. Van Sickle, M. Duncan, and P.J. Kingsley Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332
16. J.M. McPartland, and M. Glass Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates Gene 312 2003 297 303
17. M. Bari, N. Battista, F. Fezza, A. Finazzi-Agro, and M. Maccarrone Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis J Biol Chem 280 2005 12212 12220
18. S.V. Siegmund, H. Uchinami, Y. Osawa, D.A. Brenner, and R.F. Schwabe Anandamide induces necrosis in primary hepatic stellate cells Hepatology 41 2005 1085 1095
19. B.M. Fonseca, G. Correia-da-Silva, and N.A. Teixeira Anandamide-induced cell death: dual effects in primary rat decidual cell cultures Placenta 30 2009 686 692
20. E. Dainese, S. Oddi, M. Bari, and M. Maccarrone Modulation of the endocannabinoid system by lipid rafts Curr Med Chem 14 2007 2702 2715
21. M. Bari, P. Spagnuolo, and F. Fezza Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells J Immunol 177 2006 4971 4980
22. M. Begg, P. Pacher, and S. Batkai Evidence for novel cannabinoid receptors Pharmacol Ther 106 2005 133 145
23. Z. Jarai, J.A. Wagner, and K. Varga Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc Natl Acad Sci USA 96 1999 14136 14141
24. D. Baker, G. Pryce, W.L. Davies, and C.R. Hiley In silico patent searching reveals a new cannabinoid receptor Trends Pharmacol Sci 27 2006 1 4
25. M. Sawzdargo, T. Nguyen, and D.K. Lee Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain Brain Res Mol Brain Res 64 1999 193 198
26. B.M. Fonseca, N.A. Teixeira, M. Almada, A.H. Taylor, J.C. Konje, and G. Correia-da-Silva Modulation of the novel cannabinoid receptor - GPR55 - during rat fetoplacental development Placenta 32 2011 462 469
27. E. Ryberg, N. Larsson, and S. Sjogren The orphan receptor GPR55 is a novel cannabinoid receptor Br J Pharmacol 152 2007 1092 1101
28. Sharir H, Console-Bram L, Mundy C, Popoff SN, Kapur A, Abood ME The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55. J Neuroimmune Pharmacol (2012).
29. S. Oka, K. Nakajima, A. Yamashita, S. Kishimoto, and T. Sugiura Identification of GPR55 as a lysophosphatidylinositol receptor Biochem Biophys Res Commun 362 2007 928 934
30. W.A. Devane, L. Hanus, and A. Breuer Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
31. R. Mechoulam, S. Ben-Shabat, and L. Hanus Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1995 83 90
32. T. Sugiura, S. Kondo, and A. Sukagawa 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 1995 89 97
33. L. Hanus, S. Abu-Lafi, and E. Fride 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proc Natl Acad Sci USA 98 2001 3662 3665
34. A.C. Porter, J.M. Sauer, and M.D. Knierman Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 2002 1020 1024
35. S.M. Huang, T. Bisogno, and M. Trevisani An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc Natl Acad Sci USA 99 2002 8400 8405
36. S.M. Huang, T. Bisogno, and T.J. Petros Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain J Biol Chem 276 2001 42639 42644
37. J.D. Leggett, S. Aspley, S.R.G. Beckett, A.M. D'Antona, D.A. Kendall, and D.A. Kendall Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors Br J Pharmacol 141 2004 253 262
38. S. Oddi, F. Fezza, and N. Pasquariello Evidence for the intracellular accumulation of anandamide in adiposomes Cell Mol Life Sci 65 2008 840-50
39. S. Oddi, F. Fezza, and G. Catanzaro Pitfalls and solutions in assaying anandamide transport in cells J Lipid Res 51 2010 2435 2444
40. N. Battista, M. Di Tommaso, M. Bari, and M. Maccarrone The endocannabinoid system: an overview Front Behav Neurosci 6 2012 9
41. A.H. Taylor, A.A. Amoako, and K. Bambang Endocannabinoids and pregnancy Clin Chim Acta 411 2010 921 930
42. K.P. Sarker, S. Obara, M. Nakata, I. Kitajima, and I. Maruyama Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3 FEBS Lett 472 2000 39 44
43. M. Maccarrone, T. Lorenzon, M. Bari, G. Melino, and A. Finazzi-Agro Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors J Biol Chem 275 2000 31938 31945
44. E. Contassot, M. Tenan, V. Schnuriger, M.F. Pelte, and P.Y. Dietrich Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1 Gynecol Oncol 93 2004 182 188
45. R.G. Pertwee, A.C. Howlett, and M.E. Abood International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB Pharmacol Rev 62 2010 588 631
46. P.M. Zygmunt, J. Petersson, and D.A. Andersson Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457
47. S.E. O'Sullivan Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br J Pharmacol 152 2007 576 582
48. C.S. Breivogel, G. Griffin, V. Di Marzo, and B.R. Martin Evidence for a new G protein-coupled cannabinoid receptor in mouse brain Mol Pharmacol 60 2001 155 163
49. K. Monory, E.T. Tzavara, and J. Lexime Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice Biochem Biophys Res Commun 292 2002 231 235
50. L. De Petrocellis, and V. Di Marzo Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels J Neuroimmune Pharmacol 5 2010 103 121
51. M.J. Gunthorpe, C.D. Benham, A. Randall, and J.B. Davis The diversity in the vanilloid (TRPV) receptor family of ion channels Trends Pharmacol Sci 23 2002 183 191
52. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
53. V. Di Marzo, T. Bisogno, and L. De Petrocellis Anandamide: some like it hot Trends Pharmacol Sci 22 2001 346 349
54. K. Starowicz, W. Makuch, and M. Osikowicz Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms Neuropharmacology 62 2012 1746 1755
55. T. Bisogno, M. MacCarrone, and L. De Petrocellis The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors Eur J Biochem 268 2001 1982 1989
56. M. Beltramo, and D. Piomelli Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol Neuroreport 11 2000 1231 1235
57. M. Bouaboula, S. Hilairet, J. Marchand, L. Fajas, G. Le Fur, and P. Casellas Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation Eur J Pharmacol 517 2005 174 181
58. Du, H., Chen, X., Zhang, J., and Chen, C. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-gamma. Br J Pharmacol (2011).
59. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778
60. B.M. Fonseca, G. Correia-da-Silva, and A.H. Taylor N-acylethanolamine levels and expression of their metabolizing enzymes during pregnancy Endocrinology 151 2010 3965 3974
61. B.M. Fonseca, G. Correia-da-Silva, and A.H. Taylor The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: a role in uterine remodelling Int J Biochem Cell Biol 42 2010 1884 1892
62. S.V. Siegmund, T. Qian, and S. de Minicis The endocannabinoid 2-arachidonoyl glycerol induces apoptosis in primary hepatic stellate cells via membrane cholesterol and mitochondrial ros production independently of cannabinoid-receptors or nadph oxidase activation J Hepatol 46 2007 S133
63. S. DeMorrow, S. Glaser, and H. Francis Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts J Biol Chem 282 2007 13098 13113
64. G. Frampton, M. Coufal, H. Li, J. Ramirez, and S. DeMorrow Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling Exp Cell Res 316 2010 1465 1478
65. T. Sugiura, S. Kishimoto, S. Oka, and M. Gokoh Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand Prog Lipid Res 45 2006 405 446
66. V. Di Marzo, F. Piscitelli, and R. Mechoulam Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes Handb Exp Pharmacol 2011 75 104
67. S. Oka, A. Tsuchie, and A. Tokumura Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species J Neurochem 85 2003 1374 1381
68. J.L. Shoemaker, B.K. Joseph, M.B. Ruckle, P.R. Mayeux, and P.L. Prather The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors J Pharmacol Exp Ther 314 2005 868 875
69. E. Paldyova, E. Bereczki, M. Santha, T. Wenger, A. Borsodi, and S. Benyhe Noladin ether a putative endocannabinoid inhibits mu-opioid receptor activation via CB2 cannabinoid receptors Neurochem Int 52 2008 321 328
70. Sun, Y. Alexander, S.P. Kendall, D.A. Bennett, and A.J. Cannabinoids PPARalpha signalling Biochem Soc Trans 34 2006 1095 1097
71. R. Mechoulam, E. Fride, and V. Di Marzo Endocannabinoids Eur J Pharmacol 359 1998 1 18
72. W.S. Ho, and C.R. Hiley Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery J Pharm Pharmacol 56 2004 869 875
73. H. Kozlowska, M. Baranowska, E. Schlicker, M. Kozlowski, J. Laudanski, and B. Malinowska Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product Br J Pharmacol 155 2008 1034 1042
74. S.P. Markey, T. Dudding, and T.C. Wang Base- and acid-catalyzed interconversions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analyses J Lipid Res 41 2000 657 662
75. T. Bisogno, D. Melck, and M. Bobrov N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Biochem J 351 Pt 3 2000 817 824
76. T. Sheskin, L. Hanus, J. Slager, Z. Vogel, and R. Mechoulam Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor J Med Chem 40 1997 659 667
77. H.B. Bradshaw, N. Rimmerman, and S.S. Hu The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways BMC Biochem 10 2009 14
78. S.H. Burstein, S.M. Huang, T.J. Petros, R.G. Rossetti, J.M. Walker, and R.B. Zurier Regulation of anandamide tissue levels by N-arachidonylglycine Biochem Pharmacol 64 2002 1147 1150
79. M. Grazia Cascio, A. Minassi, A. Ligresti, G. Appendino, S. Burstein, and V. Di Marzo A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase Biochem Biophys Res Commun 314 2004 192 196
80. J.J. Prusakiewicz, P.J. Kingsley, K.R. Kozak, and L.J. Marnett Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2 Biochem Biophys Res Commun 296 2002 612 617
81. L.A. Vuong, V.A. Mitchell, and C.W. Vaughan Actions of N-arachidonyl-glycine in a rat neuropathic pain model Neuropharmacology 54 2008 189 193
82. G. Barbara, A. Alloui, and J. Nargeot T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids J Neurosci 29 2009 13106 13114
83. H.J. Jeong, R.J. Vandenberg, and C.W. Vaughan N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn Br J Pharmacol 161 2010 925 935
84. M. Kohno, H. Hasegawa, and A. Inoue Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18 Biochem Biophys Res Commun 347 2006 827 832
85. D. McHugh, S.S. Hu, and N. Rimmerman N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor BMC Neurosci 11 2010 44
86. S.H. Burstein, C.A. McQuain, A.H. Ross, R.A. Salmonsen, and R.E. Zurier Resolution of inflammation by N-arachidonoylglycine J Cell Biochem 112 2011 3227 3233
87. N. Parmar, and W.S. Ho N-arachidonoyl glycine an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels Br J Pharmacol 160 2010 594 603
88. H.R. Ross, A.J. Gilmore, and M. Connor Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine Br J Pharmacol 156 2009 740 750
89. B.F. Cravatt, O. Prosperogarcia, and G. Siuzdak Chemical characterization of a family of brain lipids that induce sleep Science 268 1995 1506 1509
90. T. Sugiura, S. Kondo, and T. Kodaka Enzymatic synthesis of oleamide (cis-9,10-octadenoamide), an endogenous sleep-inducing lipid, by rat brain microsomes Biochem Mol Biol Int 40 1996 931 938
91. T. Bisogno, N. Sepe, L. DePetrocellis, R. Mechoulam, and V. DiMarzo The sleep inducing factor oleamide is produced by mouse neuroblastoma cells Biochem Biophys Res Commun 239 1997 473 479
92. D.L. Boger, R.A. Fecik, J.E. Patterson, H. Miyauchi, M.P. Patricelli, and B.F. Cravatt Fatty acid amide hydrolase substrate specificity Bioorg Med Chem Lett 10 2000 2613 2616
93. D.M. Lambert, and V. Di Marzo The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem 6 1999 757 773
94. Y. Okamoto, J. Morishita, K. Tsuboi, T. Tonai, and N. Ueda Molecular characterization of a phospholipase D generating anandamide and its congeners J Biol Chem 279 2004 5298 5305
95. J. Wang, Y. Okamoto, J. Morishita, K. Tsuboi, A. Miyatake, and N. Ueda Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family J Biol Chem 281 2006 12325 12335
96. B.F. Cravatt, K. Demarest, and M.P. Patricelli Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc Natl Acad Sci USA 98 2001 9371 9376
97. N. Ueda, K. Yamanaka, Y. Terasawa, and S. Yamamoto An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors FEBS Lett 454 1999 267 270
98. N. Ueda, K. Yamanaka, and S. Yamamoto Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance J Biol Chem 276 2001 35552 35557
99. N.R. Bachur, K. Masek, K.L. Melmon, and S. Udenfriend Fatty acid amides of ethanolamine in mammalian tissues J Biol Chem 240 1965 1019 1024
100. S. Kondo, T. Sugiura, T. Kodaka, N. Kudo, K. Waku, and A. Tokumura Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis Arch Biochem Biophys 354 1998 303 310
101. P.C. Schmid, R.J. Krebsbach, S.R. Perry, T.M. Dettmer, J.L. Maasson, and H.H. Schmid Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain FEBS Lett 375 1995 117 120
102. E.V. Berdyshev, E. Boichot, N. Germain, N. Allain, J.P. Anger, and V. Lagente Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells Eur J Pharmacol 330 1997 231 240
103. A. Calignano, G. La Rana, A. Giuffrida, and D. Piomelli Control of pain initiation by endogenous cannabinoids Nature 394 1998 277 281
104. N.M. Gulaya, A.I. Kuzmenko, and V.M. Margitich Long-chain N-acylethanolamines inhibit lipid peroxidation in rat liver mitochondria under acute hypoxic hypoxia Chem Phys Lipids 97 1998 49 54
105. J. Lo Verme, J. Fu, and G. Astarita The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide Mol Pharmacol 67 2005 15 19
106. W.S. Ho, D.A. Barrett, and M.D. Randall 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors Br J Pharmacol 155 2008 837 846
107. J. Fu, S. Gaetani, and F. Oveisi Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha Nature 425 2003 90 93
108. N.L. Cluny, C.M. Keenan, B. Lutz, D. Piomelli, and K.A. Sharkey The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice Neurogastroenterol Motil 21 2009 420 429
109. H.A. Overton, A.J. Babbs, and S.M. Doel Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents Cell Metab 3 2006 167 175
110. X. Wang, R.L. Miyares, and G.P. Ahern Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1 J Physiol 564 2005 541 547
111. M. Suardiaz, G. Estivill-Torrus, C. Goicoechea, A. Bilbao, and F. Rodriguez de Fonseca Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain Pain 133 2007 99 110
112. A. Ambrosini, G. Zolese, and S. Ambrosi Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility Biol Reprod 74 2006 659 665
113. H.S. Hansen, B. Moesgaard, H.H. Hansen, and G. Petersen N-acylethanolamines and precursor phospholipids - relation to cell injury Chem Phys Lipids 108 2000 135 150
114. M. Maccarrone, R. Pauselli, M. Di Rienzo, and A. Finazzi-Agro Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells Biochem J 366 2002 137 144
115. D.M. Lambert, F.G. DiPaolo, and P. Sonveaux Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors Biochim Biophys Acta 1440 1999 266 274
116. G. Griffin, Q. Tao, and M.E. Abood Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor J Pharmacol Exp Ther 292 2000 886 894
117. T. Bisogno, S. Maurelli, D. Melck, L. De Petrocellis, and V. Di Marzo Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes J Biol Chem 272 1997 3315 3323
118. K.O. Jonsson, S. Vandevoorde, D.M. Lambert, G. Tiger, and C.J. Fowler Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide Br J Pharmacol 133 2001 1263 1275
119. S. Maurelli, T. Bisogno, L. De Petrocellis, A. Di Luccia, G. Marino, and V. Di Marzo Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase' FEBS Lett 377 1995 82 86
120. L. De Petrocellis, J.B. Davis, and V. Di Marzo Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors FEBS Lett 506 2001 253 256
121. S. Ben-Shabat, E. Fride, and T. Sheskin An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity Eur J Pharmacol 353 1998 23 31
122. F. Rakhshan, T.A. Day, R.D. Blakely, and E.L. Barker Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells J Pharmacol Exp Ther 292 2000 960 967
123. C.J. Hillard Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol Prostaglandins Other Lipid Mediat 61 2000 3 18
124. C.J. Hillard, and W.B. Campbell Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid J Lipid Res 38 1997 2383 2398
125. H. Cadas, S. Gaillet, M. Beltramo, L. Venance, and D. Piomelli Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP J Neurosci 16 1996 3934 3942
126. B. Moesgaard, G. Petersen, J.W. Jaroszewski, and H.S. Hansen Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study J Lipid Res 41 2000 985 990
127. B. Moesgaard, H.H. Hansen, S.L. Hansen, S.H. Hansen, G. Petersen, and H.S. Hansen Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure Lipids 38 2003 387 390
128. D. Leung, A. Saghatelian, G.M. Simon, and B.F. Cravatt Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids Biochemistry 45 2006 4720 4726
129. M.J. McFarland, A.C. Porter, F.R. Rakhshan, D.S. Rawat, R.A. Gibbs, and E.L. Barker A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide J Biol Chem 279 2004 41991 41997
130. J. Liu, L. Wang, and J. Harvey-White A biosynthetic pathway for anandamide Proc Natl Acad Sci USA 103 2006 13345 13350
131. G.M. Simon, and B.F. Cravatt Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway J Biol Chem 281 2006 26465 26472
132. N. Ueda, Y. Kurahashi, K. Yamamoto, S. Yamamoto, and T. Tokunaga Enzymes for anandamide biosynthesis and metabolism J Lipid Mediat Cell Signal 14 1996 57 61
133. T. Sugiura, S. Kondo, and A. Sukagawa N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues J Lipid Mediat Cell Signal 14 1996 51 56
134. N. Ueda, Y. Kurahashi, S. Yamamoto, and T. Tokunaga Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide J Biol Chem 270 1995 23823 23827
135. Y. Kurahashi, N. Ueda, H. Suzuki, M. Suzuki, and S. Yamamoto Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase Biochem Biophys Res Commun 237 1997 512 515
136. B. Mukhopadhyay, R. Cinar, and S. Yin Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver Proc Natl Acad Sci USA 108 2011 6323 6328
137. S.M. Prescott, and P.W. Majerus Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate J Biol Chem 258 1983 764 769
138. S. Nakane, S. Oka, and S. Arai 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain Arch Biochem Biophys 402 2002 51 58
139. N. Stella, and D. Piomelli Receptor-dependent formation of endogenous cannabinoids in cortical neurons Eur J Pharmacol 425 2001 189 196
140. S.T. Glaser, N.A. Abumrad, F. Fatade, M. Kaczocha, K.M. Studholme, and D.G. Deutsch Evidence against the presence of an anandamide transporter Proc Natl Acad Sci USA 100 2003 4269 4274
141. M. Kaczocha, A. Hermann, S.T. Glaser, I.N. Bojesen, and D.G. Deutsch Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase J Biol Chem 281 2006 9066 9075
142. D.G. Deutsch, S.T. Glaser, and J.M. Howell The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase J Biol Chem 276 2001 6967 6973
143. C.J. Hillard, and A. Jarrahian Cellular accumulation of anandamide: consensus and controversy Br J Pharmacol 140 2003 802 808
144. M. Kaczocha, S.T. Glaser, and D.G. Deutsch Identification of intracellular carriers for the endocannabinoid anandamide Proc Natl Acad Sci USA 106 2009 6375 6380
145. S. Oddi, F. Fezza, and N. Pasquariello Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins Chem. Biol 16 2009 624-32
146. M. Maccarrone, E. Dainese, and S. Oddi Intracellular trafficking of anandamide: new concepts for signaling Trends Biochem Sci 35 2010 601 608
147. M. Egertova, D.K. Giang, B.F. Cravatt, and M.R. Elphick A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain Proc Biol Sci 265 1998 2081 2085
148. K. Tsou, M.I. Nogueron, and S. Muthian Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry Neurosci Lett 254 1998 137 140
149. M. Beltramo, N. Stella, A. Calignano, S.Y. Lin, A. Makriyannis, and D. Piomelli Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1997 1094 1097
150. C.J. Hillard, W.S. Edgemond, A. Jarrahian, and W.B. Campbell Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion J Neurochem 69 1997 631 638
151. A. Calignano, G. La Rana, M. Beltramo, A. Makriyannis, and D. Piomelli Potentiation of anandamide hypotension by the transport inhibitor, AM404 Eur J Pharmacol 337 1997 R1 R2
152. A.K. Dickason-Chesterfield, S.R. Kidd, and S.A. Moore Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors Cell Mol Neurobiol 26 2006 407-23
153. A. Ligresti, E. Morera, and M. Van Der Stelt Further evidence for the existence of a specific process for the membrane transport of anandamide Biochem J 380 2004 265 272
154. Chicca A, Marazzi J, Nicolussi S, Gertsch J. Evidence for bidirectional endocannabinoid transport across cell membranes. J Biol Chem (2012).
155. J. Fu, G. Bottegoni, and O. Sasso A catalytically silent FAAH-1 variant drives anandamide transport in neurons Nat Neurosci 15 2012 64 69
156. M.L. Yates, and E.L. Barker Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol Mol Pharmacol 76 2009 11 17
157. D.G. Deutsch, and S.A. Chin Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist Biochem Pharmacol 46 1993 791 796
158. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
159. W.S. Ho, and M.D. Randall Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol Br J Pharmacol 150 2007 641 651
160. P. Pacher, S. Batkai, and D. Osei-Hyiaman Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase Am J Physiol Heart Circ Physiol 289 2005 H533 H541
161. B.Q. Wei, T.S. Mikkelsen, M.K. McKinney, E.S. Lander, and B.F. Cravatt A second fatty acid amide hydrolase with variable distribution among placental mammals J Biol Chem 281 2006 36569 36578
162. R.A. Ross, S.J. Craib, and L.A. Stevenson Pharmacological characterization of the anandamide cyclooxygenase metabolite: Prostaglandin E-2 ethanolamide J Pharmacol Exp Ther 301 2002 900 907
163. M. Yu, D. Ives, and C.S. Ramesha Synthesis of prostaglandin E-2 ethanolamide from anandamide by cyclooxygenase-2 J Biol Chem 272 1997 21181 21186
164. N. Ueda, K. Yamamoto, and S. Yamamoto Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist Biochim Biophys Acta 1254 1995 127 134
165. S.J. Craib, H.C. Ellington, R.G. Pertwee, and R.A. Ross A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus Br J Pharmacol 134 2001 30 37
166. H.A. Patsos, D.J. Hicks, and R.R. Dobson The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 Gut 54 2005 1741 1750
167. R.T. Van Dross Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes Mol Cancer 48 2009 724 732
168. K. Tsuboi, L.Y. Zhao, and Y. Okamoto Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies Biochim Biophys Acta 1771 2007 623 632
169. S.K. Goparaju, N. Ueda, H. Yamaguchi, and S. Yamamoto Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand FEBS Lett 422 1998 69 73
170. T.P. Dinh, T.F. Freund, and D. Piomelli A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation Chem Phys Lipids 121 2002 149 158
171. D.M. Lambert, and C.J. Fowler The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications J Med Chem 48 2005 5059 5087
172. J.K. Makara, M. Mor, and D. Fegley Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus Nat Neurosci 8 2005 1139 1141
173. G.G. Muccioli, C. Xu, and E. Odah Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells J Neurosci 27 2007 2883 2889
174. T.P. Dinh, S. Kathuria, and D. Piomelli RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol Mol Pharmacol 66 2004 1260 1264
175. K.R. Kozak, S.W. Rowlinson, and L.J. Marnett Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2 J Biol Chem 275 2000 33744 33749
176. K.R. Kozak, R.A. Gupta, and J.S. Moody 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist J Biol Chem 277 2002 23278 23286
177. M. Maccarrone, S. Salvati, M. Bari, and A. Finazzi Anandamide and
178. M. van der Stelt, J.A. van Kuik, and M. Bari Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase J Med Chem 45 2002 3709-20
179. J.L. Blankman, G.M. Simon, and B.F. Cravatt A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol Chem Biol 14 2007 1347 1356
180. S.M. Saario, O.M. Salo, and T. Nevalainen Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes Chem Biol 12 2005 649 656
181. N.T. Snider, A.M. Kornilov, U.M. Kent, and P.F. Hollenberg Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides J Pharmacol Exp Ther 321 2007 590 597
182. J. Chen, J.K. Chen, and J.R. Falck Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite Mol Cell Biol 27 2007 3023 3034
183. S.M. Foord, T.I. Bonner, and R.R. Neubig International Union of Pharmacology. XLVI. G protein-coupled receptor list Pharmacol Rev 57 2005 279 288
184. M.R. Wade, E.T. Tzavara, and G.G. Nomikos Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study Brain Res 1005 2004 117 123
185. M. Bouaboula, C. Poinot-Chazel, and B. Bourrie Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem J 312 Pt 2 1995 637 641
186. R.G. Pertwee Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development Expert Opin Investig Drugs 9 2000 1553 1571
187. M. Glass, and C.C. Felder Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor J Neurosci 17 1997 5327 5333
188. Y.P. Maneuf, and J.M. Brotchie Paradoxical action of the cannabinoid WIN 55, 212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices Br J Pharmacol 120 1997 1397 1398
189. A. Greenhough, H.A. Patsos, A.C. Williams, and C. Paraskeva The cannabinoid Delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells Int J Cancer 121 2007 2172 2180
190. D.A. Karanian, Q.B. Brown, A. Makriyannis, and B.A. Bahr Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus Eur J Pharmacol 508 2005 47 56
191. D. Rueda, I. Galve-Roperh, A. Haro, and M. Guzman The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase Mol Pharmacol 58 2000 814 820
192. D. Rueda, B. Navarro, A. Martinez-Serrano, M. Guzman, and I. Galve-Roperh The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway J Biol Chem 277 2002 46645 46650
193. W. Twitchell, S. Brown, and K. Mackie Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons J Neurophysiol 78 1997 43 50
194. S.D. McAllister, G. Griffin, L.S. Satin, and M.E. Abood Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system J Pharmacol Exp Ther 291 1999 618 626
195. G. Velasco, I. Galve-Roperh, C. Sanchez, C. Blazquez, A. Haro, and M. Guzman Cannabinoids and ceramide: two lipids acting hand-by-hand Life Sci 77 2005 1723 1731
196. C. Sanchez, I. Galve-Roperh, D. Rueda, and M. Guzman Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta(9)-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes Mol Pharmacol 54 1998 834 843
197. I. Galve-Roperh, C. Sanchez, M.L. Cortes, T.G. del Pulgar, M. Izquierdo, and M. Guzman Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation Nat Med 6 2000 313 319
198. C. Sanchez, D. Rueda, B. Segui, I. Galve-Roperh, T. Levade, and M. Guzman The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan Mol Pharmacol 59 2001 955 959
199. J.L. Niehaus, Y. Liu, and K.T. Wallis CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a Mol Pharmacol 72 2007 1557 1566
200. L. Martini, M. Waldhoer, and M. Pusch Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1 FASEB J 21 2007 802 811
201. W. Jin, S. Brown, and J.P. Roche Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization J Neurosci. 19 1999 3773 3780
202. C.C. Felder, K.E. Joyce, and E.M. Briley Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors Mol Pharmacol 48 1995 443 450
203. R.A. Ross The enigmatic pharmacology of GPR55 Trends Pharmacol Sci 30 2009 156 163
204. D.G. Demuth, and A. Molleman Cannabinoid signalling Life Sci 78 2006 549 563
205. D. Melck, D. Rueda, I. Galve-Roperh, L. De Petrocellis, M. Guzman, and V. Di Marzo Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells FEBS Lett 463 1999 235 240
206. M. Mimeault, N. Pommery, N. Wattez, C. Bailly, and J.P. Henichart Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production Prostate 56 2003 1 12
207. C. Blazquez, I. Galve-Roperh, and M. Guzman De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase FASEB J 14 2000 2315 2322
208. B. Herrera, A. Carracedo, M. Diez-Zaera, T.G. del Pulgar, M. Guzman, and G. Velasco The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway Exp Cell Res 312 2006 2121 2131
209. A. Carracedo, M. Gironella, and M. Lorente Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes Cancer Res 66 2006 6748 6755
210. F. Cianchi, L. Papucci, and N. Schiavone Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells Clin Cancer Res 14 2008 7691 7700
211. I. Galve-Roperh, D. Rueda, T.G. Del Pulgar, G. Velasco, and M. Guzman Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor Mol Pharmacol 62 2002 1385 1392
212. S.O.P. Jacobsson, T. Wallin, and C.J. Fowler Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors J Pharmacol Exp Ther 299 2001 951 959
213. S.S. Hsu, C.J. Huang, and H.H. Cheng Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells Toxicology 231 2007 21 29
214. J.C. Lim, S.K. Lim, H.J. Han, and S.H. Park Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells J Cell Physiol 225 2010 654 663
215. C. Mathay, S. Giltaire, F. Minner, E. Bera, M. Herin, and Y. Poumay Heparin-binding EGF-like growth factor is induced by disruption of lipid rafts and oxidative stress in keratinocytes and participates in the epidermal response to cutaneous wounds J Invest Dermatol 128 2008 717 727
216. R. Sancho, L. de la Vega, G. Appendino, V. Di Marzo, A. Macho, and E. Munoz The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway Br J Pharmacol 140 2003 1035 1044
217. B. Hinz, R. Ramer, K. Eichele, U. Weinzierl, and K. Brune Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells Mol Pharmacol 66 2004 1643 1651
218. S.V. Siegmund, T. Qian, and S. de Minicis The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species FASEB J 21 2007 2798 2806
219. C. Blazquez, A. Carracedo, and L. Barrado Cannabinoid receptors as novel targets for the treatment of melanoma FASEB J 20 2006 2633 2635
220. M. Salazar, A. Carracedo, and I.J. Salanueva Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells J Clin Invest 119 2009 1359 1372
221. Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz-Laviada I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ (2011).
222. C.S. Williams, M. Mann, and R.N. DuBois The role of cyclooxygenases in inflammation, cancer, and development Oncogene 18 1999 7908 7916
223. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1999 1193 1226
224. T. Kobayashi, and S. Narumiya Function of prostanoid receptors: studies on knockout mice Prostaglandins Other Lipid Mediat 68-69 2002 557 573
225. D. Wang, and R.N. Dubois Prostaglandins and cancer Gut 55 2006 115 122
226. Y.J. Surh, H.K. Na, and J.M. Park 15-Deoxy-Delta(1)(2),(1)-prostaglandin J, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling Biochem Pharmacol 82 2011 1335 1351
227. C. Ward, I. Dransfield, J. Murray, S.N. Farrow, C. Haslett, and A.G. Rossi Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism J Immunol 168 2002 6232 6243
228. C. Cocca, J. Dorado, E. Calvo, J.A. Lopez, A. Santos, and A. Perez-Castillo 15-Deoxi-Delta(12, 14)-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest Biochem Pharmacol 78 2009 1330 1339
229. K. Eichele, R. Ramer, and B. Hinz R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway Pharm Res 26 2009 346 355
230. Y.C. Chen, S.C. Shen, and S.H. Tsai Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species Biochim Biophys Acta 1743 2005 291 304
231. A.L. Levonen, D.A. Dickinson, D.R. Moellering, R.T. Mulcahy, H.J. Forman, and V.M. Darley-Usmar Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells Arterioscler Thromb Vasc Biol 21 2001 1846 1851
232. K.R. Kozak, B.C. Crews, and J.D. Morrow Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides J Biol Chem 277 2002 44877 44885
233. K.R. Kozak, and L.J. Marnett Oxidative metabolism of endocannabinoids Prostaglandins Leukot Essent Fatty Acids 66 2002 211 220
234. B.A. Berglund, D.L. Boring, and A.C. Howlett Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils Adv Exp Med Biol 469 1999 527 533
235. D.F. Woodward, A.H. Krauss, and J. Chen The pharmacology of bimatoprost (Lumigan) Surv Ophthalmol 45 Suppl 4 2001 S337 S345
236. R.A. Ross, S.J. Craib, and L.A. Stevenson Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide J Pharmacol Exp Ther 301 2002 900 907
237. I. Matias, J. Chen, and L. De Petrocellis Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism J Pharmacol Exp Ther 309 2004 745 757
238. H.A. Patsos, A. Greenhough, and D.J. Hicks The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells Int J Oncol 37 2010 187 193
239. C.A. Rouzer, and L.J. Marnett Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids J Biol Chem 283 2008 8065 8069
240. K.R. Kozak, B.C. Crews, J.L. Ray, H.H. Tai, J.D. Morrow, and L.J. Marnett Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo J Biol Chem 276 2001 36993 36998
241. S.K. Das, B.C. Paria, I. Chakraborty, and S.K. Dey Cannabinoid ligand-receptor signaling in the mouse uterus Proc Natl Acad Sci USA 92 1995 4332 4336
242. R.T. Van Dross Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes Mol Carcinog 48 2009 724 732
243. C. Kuc, A. Jenkins, and R.T. Van Dross Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade Mol Carcinog 51 2012 139 149
244. F. Correa, F. Docagne, and L. Mestre A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells Biochem Pharmacol 77 2009 86 100
245. D.F. Woodward, A.H. Krauss, and J. Chen Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther 305 2003 772 785
246. D.F. Woodward, A.H. Krauss, and J.W. Wang Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin- ethanolamides) in the feline iris Br J Pharmacol 150 2007 342 352
247. S.S. Hu, H.B. Bradshaw, J.S. Chen, B. Tan, and J.M. Walker Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity Br J Pharmacol 153 2008 1538 1549
248. N. Sang, J. Zhang, and C. Chen COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity J Neurochem 102 2007 1966 1977
249. N. Sang, J. Zhang, and C. Chen PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons J Physiol 572 2006 735 745
250. H. Yang, J. Zhang, K. Andreasson, and C. Chen COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity Mol Cell Neurosci 37 2008 682 695
251. A.J. Hampson, W.A. Hill, and M. Zan-Phillips Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor Biochim Biophys Acta 1259 1995 173 179
252. E.M. Awumey, S.K. Hill, D.I. Diz, and R.D. Bukoski Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2 + -induced relaxation of rat mesenteric arteries Am J Physiol Heart Circ Physiol 294 2008 H2363 H2370